Table 5.
Target Node (s) | Target Value | Evidence (Patient Type) | |||
---|---|---|---|---|---|
ALS | Control | N-Control | Parkinson | ||
None | None | 0.340 | 0.252 | 0.257 | 0.151 |
AGE | Below 36 | 0.119 | 0.249 | 0.106 | 0.078 |
Between 36–52 | 0.333 | 0.419 | 0.298 | 0.316 | |
Between 52–67 | 0.437 | 0.232 | 0.449 | 0.430 | |
Upper 67 | 0.111 | 0.100 | 0.148 | 0.175 | |
SEX | Female | 0.382 | 0.342 | 0.401 | 0.452 |
Male | 0.618 | 0.658 | 0.599 | 0.548 | |
PARKIN Level (ng/mL) | Upper than 3.74 | 0.244 | 0.107 | 0.098 | 0.114 |
Between 2.79–3.74 | 0.078 | 0.072 | 0.100 | 0.084 | |
Between 2.06–2.79 | 0.192 | 0.200 | 0.159 | 0.131 | |
Between 1.36–2.06 | 0.238 | 0.279 | 0.340 | 0.107 | |
Lower than 1.36 | 0.247 | 0.343 | 0.303 | 0.563 | |
UMN | No | 0.273 | 0.840 | 0.844 | 0.733 |
Yes | 0.727 | 0.160 | 0.156 | 0.267 | |
LMN | No | 0.822 | 0.912 | 0.913 | 0.852 |
Yes | 0.178 | 0.088 | 0.087 | 0.148 | |
BULBAR | No | 0.853 | 0.924 | 0.925 | 0.872 |
Yes | 0.147 | 0.076 | 0.075 | 0.128 | |
Total Number of Patience | None | 0.040 | 0.696 | 0.288 | 0.075 |
One | 0.704 | 0.189 | 0.595 | 0.731 | |
Two | 0.140 | 0.060 | 0.059 | 0.101 | |
Three | 0.103 | 0.042 | 0.045 | 0.070 | |
Four | 0.008 | 0.008 | 0.007 | 0.013 | |
Five | 0.006 | 0.006 | 0.006 | 0.010 |